Burning Rock Biotech Ltd (BNR) stock
BNRNasdaqServices-Medical Laboratories
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$12.50−0.24 (-1.88%)
Close on Nov 17, 2026Market cap $136.07MP/E –Yield –
Burning Rock Biotech operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was -10.2%, against -69.3% the year before. The highest annual figure on record is -10.2% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -10.2% | +59.2 |
| FY2024 | Dec 31, 2024 | -69.3% | +55.2 |
| FY2023 | Dec 31, 2023 | -124.5% | +49.5 |
| FY2022 | Dec 31, 2022 | -174.1% | −17.1 |
| FY2021 | Dec 31, 2021 | -156.9% | −61.0 |
| FY2020 | Dec 31, 2020 | -95.9% | −51.6 |
| FY2019 | Dec 31, 2019 | -44.3% | +33.0 |
| FY2018 | Dec 31, 2018 | -77.3% | – |
See a number that looks wrong?